Cabozantinib enhances anti-PD1 efficacy and elicits a neutrophil-based immune response in murine models: implications for human HCC
Ontology highlight
ABSTRACT: Cabozantinib enhances anti-PD1 efficacy and elicits a neutrophil-based immune response in murine models: implications for human HCC
PROVIDER: PRJNA730558 | ENA |
REPOSITORIES: ENA
ACCESS DATA